University of Oxford
Elizabeth A. Ashley focuses on Malaria, Plasmodium falciparum, Artemisinin, Artesunate and Drug resistance. Her Malaria study is related to the wider topic of Immunology. Her Plasmodium falciparum research includes elements of Virology, Selective sweep, Haplotype, Single-nucleotide polymorphism and Pharmacology.
Elizabeth A. Ashley works in the field of Artemisinin, namely Dihydroartemisinin/piperaquine. She has included themes like Artemether, Internal medicine, Piperaquine, Plasmodium vivax and Mefloquine in her Artesunate study. Her studies in Drug resistance integrate themes in fields like Genome, Combination therapy and Genotype.
Elizabeth A. Ashley mainly focuses on Malaria, Plasmodium falciparum, Artemisinin, Internal medicine and Artesunate. Her work investigates the relationship between Malaria and topics such as Pharmacology that intersect with problems in Dihydroartemisinin. Her work deals with themes such as Drug resistance and Virology, which intersect with Plasmodium falciparum.
Her Artemisinin study combines topics in areas such as Clearance rate, Multiple drug resistance, Parasite hosting and Combination therapy. Her biological study deals with issues like Surgery, which deal with fields such as Pregnancy. Her Artesunate research is multidisciplinary, relying on both Quinine and Mefloquine.
Malaria, Internal medicine, Plasmodium falciparum, Artemisinin and Antibiotic resistance are her primary areas of study. Her Malaria research incorporates elements of Algorithm, Feature and Genetic epidemiology. Her Plasmodium falciparum study incorporates themes from Drug resistance and Virology.
Her work carried out in the field of Drug resistance brings together such families of science as Single-nucleotide polymorphism, Genotype and Medical emergency. Elizabeth A. Ashley has researched Artemisinin in several fields, including Mefloquine, Tolerability, Parasitemia and Parasite hosting. Her biological study spans a wide range of topics, including Global health and Psychological intervention.
Elizabeth A. Ashley spends much of her time researching Plasmodium falciparum, Malaria, Artemisinin, Internal medicine and Meta-analysis. The Plasmodium falciparum study combines topics in areas such as Drug resistance, Genotype and Virology. Her Malaria research focuses on Plasmodium vivax in particular.
Her studies deal with areas such as Parasitemia and Parasite hosting as well as Artemisinin. Elizabeth A. Ashley interconnects Antimicrobial susceptibility and Mefloquine in the investigation of issues within Internal medicine. Her Piperaquine research is multidisciplinary, incorporating elements of Global health and Dihydroartemisinin/piperaquine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley Ea;Dhorda M;Fairhurst Rm;Amaratunga C.
The New England Journal of Medicine (2014)
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Aung Pyae Phyo;Standwell Nkhoma;Kasia Stepniewska;Kasia Stepniewska;Elizabeth A. Ashley;Elizabeth A. Ashley.
The Lancet (2012)
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
Ric N. Price;Ric N. Price;Anne Catrin Uhlemann;Alan Brockman;Rose McGready.
The Lancet (2004)
Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data
EA Ashley;F Aweeka;KI Barnes;Q Bassat.
BMC Medicine (2015)
Genetic architecture of artemisinin-resistant Plasmodium falciparum.
O Miotto;R Amato;E A Ashley;B MacInnis.
Nature Genetics (2015)
A Major Genome Region Underlying Artemisinin Resistance in Malaria
Ian H. Cheeseman;Becky A. Miller;Shalini Nair;Standwell Nkhoma.
Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker
Kyaw M. Tun;Mallika Imwong;Khin M Lwin;Aye A. Win.
Lancet Infectious Diseases (2015)
Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance
Sachel Mok;Elizabeth A. Ashley;Elizabeth A. Ashley;Pedro E. Ferreira;Lei Zhu.
Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment
Verena Ilona Carrara;Julien Zwang;Elizabeth A. Ashley;Elizabeth A. Ashley;Ric N. Price;Ric N. Price.
PLOS ONE (2009)
Genomic epidemiology of artemisinin resistant malaria
A. Amato;A. Amato;O. Miotto;O. Miotto;O. Miotto;C.J. Woodrow;C.J. Woodrow;J. Almagro-Garcia;J. Almagro-Garcia.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: